Jean-Luc Perfettini

Dr. Jean-Luc Perfettini is the co-Director of the INSERM Unit UMR 1030 and Director of the Cell Death, Immunity and Therapeutic Innovation at Gustave Roussy. He has developed an internationally recognized expertise in the cell death processes and innate immune responses elicited by anticancer treatment. Dr. JL. PERFETTINI is the scientific coordinator of Gustave Roussy’s emerging medical-scientific program in biotherapy (www.gustaveroussy.fr/en/emerging-biotherapeutics-program) and research programs dedicated to the development of novel myeloid cell therapy for pediatric and young adult cancers and hard-to-treat solid cancers He co-authored more than 83 publications (including articles in Nat Immunol, Nat Med, Nat Cell Biol, Nat Commun, JEM, Cell Death Differ, EMBO J and Cell Reports), and filed 14 patents.